| 効果 | なし |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 23 |
| 性別 | 男女 |
| 年齢 | 45-64, 65+ |
| 体型 | 平均 |
Supplementation of the standard doses of creatine during a loading phase (0.3g/kg bodyweight) and maintenance phase (0.07g/kg) failed to improve cardiovascular or muscular performance any more than placebo in persons with COPD; lung function and quality of life were similarly unaffected.
Randomized Controlled Trial Of Dietary Creatine As An Adjunct Therapy To Physical Training In Chronic Obstructive Pulmonary Disease
| 効果 | なし |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 80 |
| 性別 | 男女 |
| 年齢 | 65+ |
| 体型 | 肥満 |
Supplementation of persons with creatine at 22g daily for a five day loading phase (with 20g lactose) and then a maintenance phase of 3.76g creatine (5g lactose) daily for a period of seven weeks failed to increase any parameter of physical performance or muscular strength relative to placebo, despite a weight gain seen with supplementation.
Creatine Supplementation During Pulmonary Rehabilitation In Chronic Obstructive Pulmonary Disease
| 効果 | 増加 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 25 |
| 性別 | 男女 |
| 年齢 | 45-64 |
| 体型 | 平均 |
In persons with COPD given supplementation of either placebo (glucose) or creatine (5.7g) with glucose (35.7g) thrice daily to match placebo over two weeks, then with 5.7g once daily for 11 weeks, supplementation was associated with improvements in muscular strength and well being as well as an increase in weight that was not fat mass; cardiovascular exercise performance, however, was unaffected.